KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

This was the stock's second consecutive day of gains.

Kimberly-Clark (KMB) stock faces risks from the $48.7B Kenvue acquisition, high debt, and weak growth. Learn why analysts ...

Kenvue has a lower P/E than the aggregate P/E of 55.57 of the Personal Products industry. Ideally, one might believe that the ...

"I will not allow Big Pharma to operate above the law or put their greed ahead of Texans’ well-being," said Paxton.

After recently coming under pressure, these three dividend stocks have both yield and rebound potential.

Kimberly-Clark’s agreement to acquire Kenvue will create a U.S. consumer health and hygiene leader with the scale to compete ...

A Texas judge has ordered Tylenol-maker Kenvue Inc. and its former parent Johnson & Johnson to register with the Texas Secretary of State or risk being barred from doing business in the state.

Attorney General Paxton secured a court order against Johnson & Johnson and Kenvue for operating without proper registration ...

Tylenol-maker Kenvue Inc. must comply with a Texas law requiring out-of-state businesses to register with the state or risk ...

Some big US companies want to shift domicile to Nevada and Texas in a move that is upending the world of business law ...

These five top blue chip dividend stocks offer growth and income investors a solid opportunity to generate passive income and total return.